Modulating Target Protein Biology Through the Re-mapping of Conformational Distributions Using Small Molecules

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Significant advancements in small molecule modulators of protein-protein interactions (PPIs) over the last decade.
• Structure-based design has been pivotal, guiding medicinal chemistry for drug candidates.
• Emerging recognition of the importance of protein dynamics (movement and time) in drug discovery.

Purpose of the Study:

• To highlight novel opportunities for small molecules in modulating disease biology.
• To explore the application of protein dynamics in targeting PPIs.
• To discuss strategies for stabilizing desired protein conformers.

Main Methods:

• Leveraging increased computing power for analyzing protein dynamics.
• Integrating computational approaches with wet lab validation.
• Utilizing structure-based design principles informed by dynamic properties.

Main Results:

• Protein dynamics offer new avenues for drug discovery, targeting previously inaccessible allosteric sites.
• Small molecules can influence PPIs by modulating the frequency profile of conformational sampling.
• Stabilization of specific protein conformers presents a promising therapeutic strategy.

Conclusions:

• Protein dynamics are crucial for understanding and treating diseases.
• Modulating protein dynamics with small molecules significantly broadens the scope of PPI drug discovery.
• This dynamic approach enables the development of novel therapeutics for various diseases.